
Michael Farwell
Associate Professor of Radiology at the Hospital of the University of Pennsylvania · University of Pennsylvania Health System
Credentials: · · · · · ·
History

- 2008–2012
- 2008–2011
- 2007–2008
- 2007–2008


- 1999–2003
1997–2002
Research
A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma
Nature Medicine · 2019 · 588 citations
Nature Medicine · 2022 · 466 citations
Journal of Nuclear Medicine · 2020 · 210 citations

18 papers

13 papers

12 papers · 2 as a fellow

6 papers

6 papers

5 papers

5 papers

4 papers · 4 as a fellow
Grants
- 2024–2029
Dual-Targeted DOTA CAR T Cells with Image-Guided Monitoring for Solid Tumor Treatment
National Cancer Institute · UH3
PI · $1.9M · University of Pennsylvania
- 2023–2028
National Cancer Institute · R01
Contact PI · $1.9M · University of Pennsylvania
- 2024–2026
Dual-Targeted DOTA CAR T Cells with Image-Guided Monitoring for Solid Tumor Treatment
National Cancer Institute · UG3
PI · $2.9M · University of Pennsylvania
- 2018–2023
Quantitative Control of CAR T Cells via Image-Guided Delivery and Monitoring
National Institute of Biomedical Imaging and Bioengineering · R01
PI · $2.6M · University of Pennsylvania
Clinical trials
- 2017–2021
Principal investigator · Terminated
Abramson Cancer Center at Penn Medicine
- 2016–2020
Principal investigator · Completed
Abramson Cancer Center at Penn Medicine
- 2016–2021



